Tech Company Financing Transactions
Thabor Therapeutics Funding Round
Bpifrance participated in a $2.1 million funding round for Thabor Therapeutics. This VC investment round was announced on 7/6/2022.
Transaction Overview
Company Name
Announced On
7/6/2022
Transaction Type
Venture Equity
Amount
$2,090,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding will enable the company to accelerate its R&D programs for the industrial development of its monoclonal antibodies and an IND (Investigational New Drug) application and for further staff recruitment to strengthen its team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Rue Thenard
Paris, 75005
France
Paris, 75005
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Thabor therapeutics is a biotechnology company focused on treating human mucosal inflammatory diseases by inhibiting a new target that could be implied in the early inflammatory process and the recruitment of innate immunity cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jérémie Mariau
Co-Founder
Eric Chevet
Co-Founder
Eric Ogier-Denis
Co-Founder
Xavier Treton
VP - Bus. Development
Clement Bertholet
VP - R & D
Stephanie Beq
Browse more venture capital transactions:
Prev: 7/6/2022: Nuclera venture capital transaction
Next: 7/6/2022: Iceotope Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs